Skip to content

Risk score-guided dual antiplatelet therapy in Korean acute coronary syndrome patients receiving bioabsorbable-polymer everolimus eluting stent (Synergy stent)

Risk score-guided dual antiplatelet therapy in Korean acute coronary syndrome patients receiving bioabsorbable-polymer everolimus eluting stent (Synergy stent)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0006003
Enrollment
1000
Registered
2021-03-16
Start date
2020-03-16
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Chonnam National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: -Patients = 19 years old -Patients with acute coronary syndrome having lesions requiring interventions amendable for implantation of Synergy during the index procedure -Patients who voluntarily decide to participate in this research and agree to the consent form

Exclusion criteria

Exclusion criteria: -Female of childbearing potential, who possibly plans to become pregnant any time after enrollment into this study - If the life expectancy is less than three years -Patients requiring oral anticoagulation

Design outcomes

Primary

MeasureTime frame
Net adverse clinical events defined as a composite of all-cause death, myocardial infarction, repeat percutaneous coronary intervention or coronary artery bypass graft surgery, stent thrombosis, stroke, and major/minor bleeding [BARC type 3-5/1-2]

Secondary

MeasureTime frame
Major adverse cardiac and cerebrovascular events defined as a composite of all-cause death, myocardial infarction, repeat percutaneous coronary intervention or coronary artery bypass graft surgery, stent thrombosis, and stroke;All-cause death;Myocardial infarction;Repeat percutaneous coronary intervention or coronary artery bypass graft surgery;Stent thrombosis;Stroke;Major or minor bleeding [BARC type 3-5/1-2]

Countries

Korea, Republic of

Contacts

Public ContactHyojin Park

Chonnam National University Hospital

h-4427@naver.com+82-62-220-5272

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026